Clinical trial
A Study to Evaluate the Efficacy and Safety of Eplerenone in the Treatment of…
NCT00147589 · Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry · Completed
Key facts
| NCT number | NCT00147589 |
|---|---|
| Title | A Study to Evaluate the Efficacy and Safety of Eplerenone in the Treatment of Hypertension in Children. |
| Official title | Peds I (Pediatric Eplerenone Development Study I): A Randomized, Double-Blind, Placebo Withdrawal, Parallel Group, Dose-Response Study To Evaluate The Efficacy And Safety Of Eplerenone In The Treatment Of Hypertension In Children |
| Lead sponsor | Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Eplerenone |
| Enrollment | 320 |
| Start date | Sep 1, 2004 |
| Completion | Jan 1, 2007 |
| First posted | Sep 7, 2005 |
| Last update posted | Dec 22, 2020 |
| Countries | Dominican Republic, India, Russia, South Africa, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: